Christopher Frampton

21.3k total citations · 3 hit papers
352 papers, 15.3k citations indexed

About

Christopher Frampton is a scholar working on Surgery, Clinical Psychology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Christopher Frampton has authored 352 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Surgery, 57 papers in Clinical Psychology and 53 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Christopher Frampton's work include Total Knee Arthroplasty Outcomes (28 papers), Gout, Hyperuricemia, Uric Acid (27 papers) and Orthopaedic implants and arthroplasty (27 papers). Christopher Frampton is often cited by papers focused on Total Knee Arthroplasty Outcomes (28 papers), Gout, Hyperuricemia, Uric Acid (27 papers) and Orthopaedic implants and arthroplasty (27 papers). Christopher Frampton collaborates with scholars based in New Zealand, United States and Australia. Christopher Frampton's co-authors include Mark Richards, Timothy G. Yandle, Richard W. Troughton, M. Gary Nicholls, Peter R. Joyce, Murray L. Barclay, Suzanne E. Luty, John G. Lainchbury, Roger Mulder and Lisa K. Stamp and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Christopher Frampton

332 papers receiving 14.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

2000 1.0k citations Richard W. Troughton, Christopher Frampton et al. profile →
Anaesthetic depth and delirium after major surgery: a randomised clinical trial

2021 194 citations Matthew T.V. Chan, Christopher Frampton et al. profile →
Designing and validating a research questionnaire - Part 2

2024 26 citations Christopher Frampton et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Christopher Frampton	4.2k	3.1k	1.9k	1.8k	1.7k	352	15.3k
Warren S. Browner	4.3k 1.0×	5.2k 1.7×	1.8k 0.9×	1.6k 0.9×	1.0k 0.6×	132	19.4k
Mary A. Whooley	9.9k 2.4×	1.7k 0.6×	2.0k 1.1×	1000 0.6×	1.9k 1.1×	325	20.7k
F. Javier Nieto	2.7k 0.7×	2.1k 0.7×	1.7k 0.9×	1.6k 0.9×	310 0.2×	106	12.6k
Matthew Allison	8.3k 2.0×	5.8k 1.9×	2.9k 1.5×	3.5k 1.9×	1.0k 0.6×	614	25.3k
Ichiro Tsuji	5.0k 1.2×	3.3k 1.1×	2.0k 1.1×	1.6k 0.9×	1.2k 0.7×	623	21.4k
Giel Nijpels	5.1k 1.2×	2.1k 0.7×	3.6k 1.9×	1.1k 0.6×	402 0.2×	411	20.0k
Tobias Kurth	2.8k 0.7×	2.6k 0.8×	2.9k 1.5×	3.0k 1.7×	473 0.3×	350	20.3k
Thomas H. Mosley	6.5k 1.6×	3.3k 1.1×	2.5k 1.3×	2.7k 1.5×	408 0.2×	463	20.4k
Stephen Sidney	4.8k 1.2×	2.3k 0.7×	3.3k 1.7×	2.9k 1.6×	842 0.5×	234	18.2k
Stefania Maggi	2.1k 0.5×	2.8k 0.9×	2.2k 1.1×	1.1k 0.6×	936 0.5×	507	18.6k

Countries citing papers authored by Christopher Frampton

Since Specialization

Citations

This map shows the geographic impact of Christopher Frampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Frampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Frampton more than expected).

Fields of papers citing papers by Christopher Frampton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Frampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Frampton. The network helps show where Christopher Frampton may publish in the future.

Co-authorship network of co-authors of Christopher Frampton

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Frampton. A scholar is included among the top collaborators of Christopher Frampton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Frampton. Christopher Frampton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chaffin, Abigail E., et al.. (2025). Clinical Efficacy of Ovine Forestomach Matrix and Collagen/Oxidised Regenerated Cellulose for the Treatment of Venous Leg Ulcers: A Retrospective Comparative Real‐World Evidence Study. International Wound Journal. 22(4). e70368–e70368. 4 indexed citations

Woods, C., Ben Beaglehole, Christopher Frampton, Virginia V. W. McIntosh, & Caroline Bell. (2025). Psychological interventions for adult earthquake-related post-traumatic stress disorder: systematic review and meta-analysis. BJPsych Open. 11(4). e119–e119.

Hooper, Gary J., et al.. (2024). Five- and ten-year follow-up of medial unicompartmental knee arthroplasties in obese and non-obese patients. Bone & Joint Open. 5(10). 937–943.

Nelissen, Rob G. H. H., Carl Holder, Stephen E. Graves, et al.. (2024). Sex-based differences in risk of revision for infection after hip, knee, shoulder, and ankle arthroplasty in osteoarthritis patients: a multinational registry study of 4,800,000 implants. Acta Orthopaedica. 95. 730–736. 1 indexed citations

Gee, Paul, et al.. (2023). Rising Kawasaki disease incidence in New Zealand: analysis of national population incidence and outcomes 2000–2017. Archives of Disease in Childhood. 108(11). 916–921. 3 indexed citations

Tay, Mei Lin, A. Paul Monk, Christopher Frampton, Gary J. Hooper, & Simon W. Young. (2023). A comparison of clinical thresholds for revision following total and unicompartmental knee arthroplasty. The Bone & Joint Journal. 105-B(3). 269–276. 14 indexed citations

Tay, Mei Lin, Simon W. Young, Christopher Frampton, & Gary J. Hooper. (2022). The lifetime revision risk of unicompartmental knee arthroplasty. The Bone & Joint Journal. 104-B(6). 672–679. 42 indexed citations

Frampton, Christopher, et al.. (2022). Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple Sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(1). 3080433952–3080433952. 2 indexed citations

Frampton, Christopher, et al.. (2021). Retrospective real‐world comparative effectiveness of ovine forestomach matrix and collagen/ ORC in the treatment of diabetic foot ulcers. International Wound Journal. 19(4). 741–753. 14 indexed citations

10.

Boyle, Jemma M., Christopher Frampton, Elizabeth Harvey-Jones, et al.. (2021). Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study. European Journal of Cancer. 155. 136–144. 26 indexed citations

11.

Stamp, Lisa K., Christopher Frampton, William J. Taylor, et al.. (2021). Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials. The Lancet Rheumatology. 4(1). e53–e60. 33 indexed citations

12.

Merry, Alan, Ian Bissett, David Cumin, et al.. (2019). The effect of implementing an aseptic practice bundle for anaesthetists to reduce postoperative infections, the Anaesthetists Be Cleaner (ABC) study: protocol for a stepped wedge, cluster randomised, multi-site trial. Trials. 20(1). 342–342. 1 indexed citations

13.

Zhang, Jennifer, et al.. (2019). An integrated safety analysis of combined acetaminophen and ibuprofen (Maxigesic®/ Combogesic®) in adults. Journal of Pain Research. Volume 12. 621–634. 9 indexed citations

14.

Bagshaw, Philip, Christopher Frampton, Robin Gauld, et al.. (2017). Pilot study of methods for assessing unmet secondary health care need in New Zealand.. PubMed. 130(1452). 23–38. 5 indexed citations

15.

Cumin, David, Ian Civil, Jane Torrie, et al.. (2016). Improved scores for observed teamwork in the clinical environment following a multidisciplinary operating room simulation intervention.. PubMed. 129(1439). 59–67. 16 indexed citations

16.

Rocca, Hans‐Peter Brunner‐La, Luc W.M. Eurlings, Mark Richards, et al.. (2015). Which Heart Failure Patients Profit from Natriuretic Peptide Guided Therapy? a Meta-Analysis from Individual Patient Data of Randomized Trials. European Journal of Heart Failure. 17(12). 1252–1261. 67 indexed citations

17.

Short, Timothy G., Kate Leslie, Matthew T.V. Chan, et al.. (2015). Rationale and Design of the Balanced Anesthesia Study. Anesthesia & Analgesia. 121(2). 357–365. 52 indexed citations

18.

Pickering, John W., Christopher Frampton, Robert Walker, Geoffrey M. Shaw, & Zoltán Endre. (2012). Four hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients. Critical Care. 16(3). R107–R107. 55 indexed citations

19.

Pulford, Justin, Daryle Deering, Gail Robinson, et al.. (2010). Development of a routine outcome monitoring instrument for use with clients in the New Zealand Alcohol and Other Drug treatment sector: the Alcohol and Drug Outcome Measure (ADOM). Queensland's institutional digital repository (The University of Queensland). 12 indexed citations

20.

Richards, Mark, et al.. (2006). Introduction of Metoprolol Increases Plasma B-Type Cardiac Natriuretic Peptides in Mild, Stable Heart Failure. Circulation. 113(7). 977–985. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact